Adenosine A1 receptors measured with 11 C-MPDX PET in early Parkinson's disease

Caffeine and Adenosine

(2017) Joaquim A. Ribeiro et al.   JOURNAL OF ALZHEIMERS DISEASE

Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial

(2014) Robert A Hauser et al.   LANCET NEUROLOGY

Caffeine potentiates the release of GABA mediated by NMDA receptor activation: Involvement of A1 adenosine receptors

(2014) D.D.P. Ferreira et al.   NEUROSCIENCE

Novel nondopaminergic targets for motor features of Parkinson's disease: Review of recent trials

(2012) Lorraine V. Kalia et al.   MOVEMENT DISORDERS

Small-Animal PET Study of Adenosine A1 Receptors in Rat Brain: Blocking Receptors and Raising Extracellular Adenosine

(2011) S. Paul et al.   JOURNAL OF NUCLEAR MEDICINE

Adenosine A2A Receptors Measured with [11C]TMSX PET in the Striata of Parkinson's Disease Patients

(2011) Masahiro Mishina et al.   PLoS One

Recent developments in adenosine receptor ligands and their potential as novel drugs

(2010) Christa E. Müller et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

Deletion of adenosine A1 or A2A receptors reduces l-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's disease

(2010) Danqing Xiao et al.   BRAIN RESEARCH

Clinical efficacy of istradefylline (KW-6002) in Parkinson's disease: A randomized, controlled study

(2010) Yoshikuni Mizuno et al.   MOVEMENT DISORDERS

Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry

(2010) Alexxai V. Kravitz et al.   NATURE

Adenosine1 Receptor Antagonism

(2009) Rena H. Shah et al.   Cardiology in Review

Validation of cardiac 123I-MIBG scintigraphy in patients with Parkinson’s disease who were diagnosed with dopamine PET

(2009) Kenji Ishibashi et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Parkinson's disease

(2009) Andrew J Lees et al.   LANCET

Adenosine, adenosine A2A antagonists, and Parkinson's disease

(2009) P. Jenner et al.   PARKINSONISM & RELATED DISORDERS

The effects of systemic, intrastriatal, and intrapallidal injections of caffeine and systemic injections of A2A and A1 antagonists on forepaw stepping in the unilateral 6-OHDA-lesioned rat

(2008) John E. Kelsey et al.   PSYCHOPHARMACOLOGY

Chronic but not acute treatment with caffeine attenuates traumatic brain injury in the mouse cortical impact model

(2007) W. Li et al.   NEUROSCIENCE

A1 and A2A receptor activation by endogenous adenosine is required for VIP enhancement of K+-evoked [3H]-GABA release from rat hippocampal nerve terminals

(2007) Diana Cunha-Reis et al.   NEUROSCIENCE LETTERS